Have These Patients Been Immunized Appropriately?

A Case-Based Challenge

Robert H. Hopkins, Jr., MD


August 06, 2014

The Nuts and Bolts of Pneumococcal Vaccine Recommendations

Clinicians must also recognize that patients at elevated risk for pneumococcal disease require booster doses. Specifics regarding the correct administration of pneumococcal vaccine to those patients who have received previous doses are provided in Figure 4.

Figure 4. Pneumococcal vaccine recommendations. PCV13 = 13-valent pneumococcal conjugate vaccine; PPSV23 = 23-valent pneumococcal polysaccharide vaccine. Data from CDC.[1]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.